Goelzer Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.8M Sell
122,719
-4,286
-3% -$502K 0.69% 21
2026
Q1
$15.3M Sell
127,005
-955
-0.7% -$110K 0.74% 19
2025
Q4
$13.5M Buy
127,960
+964
+0.8% +$90.5K 0.62% 22
2025
Q3
$10.7M Sell
126,996
-2,169
-2% -$179K 0.56% 30
2025
Q2
$10.2M Sell
129,165
-986
-0.8% -$78.4K 0.56% 27
2025
Q1
$11.7M Sell
130,151
-894
-0.7% -$83.5K 0.68% 24
2024
Q4
$13M Sell
131,045
-2,960
-2% -$305K 0.76% 19
2024
Q3
$15.2M Sell
134,005
-1,354
-1% -$161K 0.83% 15
2024
Q2
$16.8M Sell
135,359
-1,836
-1% -$236K 0.94% 13
2024
Q1
$18.1M Sell
137,195
-4,386
-3% -$541K 1.03% 12
2023
Q4
$15.4M Sell
141,581
-1,280
-0.9% -$133K 0.99% 12
2023
Q3
$14.7M Sell
142,861
-2,984
-2% -$322K 1.04% 12
2023
Q2
$16.8M Sell
145,845
-10,539
-7% -$1.2M 1.42% 11
2023
Q1
$16.6M Sell
156,384
-12,569
-7% -$1.36M 1.45% 10
2022
Q4
$18.7M Sell
168,953
-2,260
-1% -$231K 1.61% 12
2022
Q3
$14.7M Buy
171,213
+2,847
+2% +$254K 1.47% 10
2022
Q2
$15.3M Buy
168,366
+3,583
+2% +$318K 1.48% 11
2022
Q1
$13.5M Sell
164,783
-1,682
-1% -$133K 1.17% 15
2021
Q4
$12.8M Sell
166,465
-2,459
-1% -$196K 1.04% 14
2021
Q3
$12.7M Sell
168,924
-4,939
-3% -$376K 1.11% 14
2021
Q2
$13.5M Buy
173,863
+17,821
+11% +$1.33M 1.12% 13
2021
Q1
$11.5M Buy
156,042
+12,777
+9% +$942K 1.01% 14
2020
Q4
$11.2M Sell
143,265
-22,914
-14% -$1.75M 1.03% 16
2020
Q3
$13.2M Sell
166,179
-1,174
-0.7% -$92K 1.22% 13
2020
Q2
$12.3M Buy
167,353
+100
+0.1% +$7.53K 1.19% 16
2020
Q1
$12.3M Sell
167,253
-28,313
-14% -$2.23M 1.4% 14
2019
Q4
$17M Sell
195,566
-303
-0.2% -$24.9K 1.46% 12
2019
Q3
$15.7M Sell
195,869
-428
-0.2% -$34.3K 1.44% 12
2019
Q2
$15.7M Buy
196,297
+688
+0.4% +$52.7K 1.45% 11
2019
Q1
$15.5M Sell
195,609
-766
-0.4% -$57.3K 1.47% 10
2018
Q4
$14.3M Sell
196,375
-606
-0.3% -$42.8K 1.83% 6
2018
Q3
$13.3M Sell
196,981
-1,149
-0.6% -$73.2K 1.49% 8
2018
Q2
$11.5M Buy
198,130
+1,776
+0.9% +$100K 1.34% 10
2018
Q1
$10.2M Buy
196,354
+28,988
+17% +$1.57M 1.22% 11
2017
Q4
$8.99M Buy
167,366
+3,021
+2% +$167K 1.01% 22
2017
Q3
$10M Sell
164,345
-144
-0.1% -$8.73K 1.18% 17
2017
Q2
$10.1M Sell
164,489
-2,119
-1% -$129K 1.23% 17
2017
Q1
$10.1M Buy
166,608
+216
+0.1% +$13.1K 1.26% 18
2016
Q4
$9.35M Buy
166,392
+12,704
+8% +$743K 1.21% 18
2016
Q3
$9.15M Sell
153,688
-1,595
-1% -$93.3K 1.23% 15
2016
Q2
$8.54M Buy
155,283
+2,377
+2% +$127K 1.18% 19
2016
Q1
$7.72M Sell
152,906
-21,602
-12% -$1.06M 1.1% 19
2015
Q4
$8.79M Buy
174,508
+7,193
+4% +$363K 1.28% 12
2015
Q3
$7.88M Buy
167,315
+17,232
+11% +$915K 1.25% 12
2015
Q2
$8.15M Buy
150,083
+2,112
+1% +$118K 1.23% 11
2015
Q1
$8.12M Buy
147,971
+5,224
+4% +$296K 1.23% 10
2014
Q4
$7.74M Buy
142,747
+3,699
+3% +$206K 1.17% 13
2014
Q3
$7.87M Buy
139,048
+6,341
+5% +$356K 1.31% 8
2014
Q2
$7.33M Buy
132,707
+292
+0.2% +$15.9K 1.22% 10
2014
Q1
$7.17M Buy
132,415
+1,686
+1% +$87.3K 1.28% 9
2013
Q4
$6.24M Buy
130,729
+97
+0.1% +$4.43K 1.13% 19
2013
Q3
$5.93M Sell
130,632
-133,545
-51% -$6.1M 1.21% 15
2013
Q2
$11.7M Buy
+264,177
New +$11.8M 1.25% 11

Other funds holding MRK

Goelzer Investment Management's MRK Position: Q2 2026 in Review

Goelzer Investment Management reduced its Merck (MRK) stake by 3.4% in Q2 2026, selling an estimated $502K and leaving 122,719 shares worth $15.8M. The position accounts for 0.69% of the portfolio, ranked #21.

Goelzer Investment Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.7M in Q4 2022. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Goelzer Investment Management held 122,719 shares of Merck worth $15.8M as of Q2 2026.
  • Goelzer Investment Management sold 4,286 Merck shares in Q2 2026, an estimated $502K.
  • Merck made up 0.69% of Goelzer Investment Management's portfolio in Q2 2026, its #21 holding.
  • Goelzer Investment Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Goelzer Investment Management's Merck position peaked at $18.7M in Q4 2022.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Goelzer Investment Management's 13F filing for Q2 2026, filed 15 Jul 2026.